The efficacy and function of Rabeprazole Sodium Enteric-coated Capsules

Generally, rabeprazole sodium enteric-coated capsules are a commonly used proton pump inhibitor, primarily indicated for treating diseases caused by excessive gastric acid. Its therapeutic effects include inhibiting gastric acid secretion, treating gastroesophageal reflux disease, treating duodenal ulcers, managing Helicobacter pylori infection, and preventing gastrointestinal bleeding. Detailed explanations are as follows:

1. Inhibition of Gastric Acid Secretion

The main active ingredient of rabeprazole sodium enteric-coated capsules is rabeprazole sodium, which belongs to the class of proton pump inhibitors. Proton pumps are key enzymes in gastric parietal cells responsible for acid secretion. After administration, the drug accumulates in gastric parietal cells and irreversibly binds to cysteine residues of the proton pump, thereby inactivating it and blocking the final step of gastric acid secretion.

2. Treatment of Gastroesophageal Reflux Disease (GERD)

Gastroesophageal reflux disease is caused by excessive gastric acid or insufficient gastric motility, leading to acid reflux into the esophagus and resulting in mucosal injury and inflammation. Rabeprazole sodium enteric-coated capsules inhibit gastric acid secretion, thereby reducing gastric acid concentration and minimizing acid reflux into the esophagus, alleviating irritation and damage to the esophageal mucosa.

3. Treatment of Duodenal Ulcer

Peptic ulcers of the duodenum mainly result from excessive gastric acid production and weakened protective mechanisms of the gastric mucosa. By inhibiting gastric acid secretion, rabeprazole sodium enteric-coated capsules reduce acid erosion of the duodenal mucosa, promoting ulcer healing.

4. Treatment of Helicobacter pylori Infection

Helicobacter pylori is a bacterium that can survive in the highly acidic environment of the stomach. It produces urease, which breaks down urea into ammonia, causing inflammatory reactions, irritating the gastric mucosa, and increasing gastric acid secretion. By inhibiting gastric acid secretion, rabeprazole sodium enteric-coated capsules reduce gastric acidity, creating a more favorable environment for antibiotics to effectively eradicate Helicobacter pylori.

5. Prevention of Gastrointestinal Bleeding

Gastrointestinal bleeding may be caused by unhealthy dietary habits, peptic ulcers, acute gastritis, or other factors. Rabeprazole sodium enteric-coated capsules inhibit gastric acid secretion, reducing irritation and damage to the gastrointestinal mucosa, thus helping to prevent the occurrence of gastrointestinal bleeding.

When using rabeprazole sodium enteric-coated capsules, it is essential to strictly follow medical instructions, avoiding long-term or excessive use to prevent drug dependence or other adverse effects.